Valo submits CTA for first-in-human study of PeptiCRAd-1 in melanoma, TNBC and NSCLC July 14, 2021 No Comments
Genocea initiates phase I/IIa study of neoantigen-targeted T cell therapy GEN-011 July 14, 2021 No Comments
Enrollment ongoing in phase II study of ISA-101b vaccine plus cemiplimab in HPV16 cervical cancer July 14, 2021 No Comments
Akeso completes phase I trial of AK-117 and gains clearance for phase Ib/II trial in AML July 13, 2021 No Comments
Hummingbird and MD Anderson collaborate to advance VISTA antagonist antibody, HMBD-002 July 13, 2021 No Comments
Safety monitoring committee recommends continuation of phase IIb study of RV-001 in prostate cancer July 12, 2021 No Comments
RSS